← Every company
GSK plc SEC Filings
What GSK plc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
GSK overview →Filings on file
26
since Mar 17, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 24, 2026 | Tender offer SC TO-T | Read ↗ |
| Mar 6, 2026 | Annual report 20-F | Read ↗ |
| Feb 2, 2026 | Tender offer SC TO-T | Read ↗ |
| May 15, 2025 | Delisting 25-NSE | Read ↗ |
| Mar 3, 2025 | Annual report 20-F | Read ↗ |
| Jun 3, 2024 | Delisting 25-NSE | Read ↗ |
| Mar 5, 2024 | Annual report 20-F | Read ↗ |
| Oct 2, 2023 | Delisting 25-NSE | Read ↗ |
| Apr 17, 2023 | Annual report 20-F/A | Read ↗ |
| Mar 10, 2023 | Annual report 20-F | Read ↗ |
| Sep 15, 2022 | Delisting 25-NSE | Read ↗ |
| Sep 1, 2022 | Delisting 25-NSE | Read ↗ |
| May 9, 2022 | Delisting 25-NSE | Read ↗ |
| May 2, 2022 | Delisting 25-NSE | Read ↗ |
| Mar 8, 2022 | Annual report 20-F | Read ↗ |
| May 14, 2021 | Delisting 25-NSE | Read ↗ |
| Mar 12, 2021 | Annual report 20-F | Read ↗ |
| Oct 13, 2020 | Delisting 25-NSE | Read ↗ |
| Mar 6, 2020 | Annual report 20-F | Read ↗ |
| Mar 15, 2019 | Annual report 20-F | Read ↗ |
| Dec 14, 2018 | Tender offer SC TO-T | Read ↗ |
| May 17, 2018 | Delisting 25-NSE | Read ↗ |
| Mar 20, 2018 | Annual report 20-F/A | Read ↗ |
| Mar 16, 2018 | Annual report 20-F | Read ↗ |
| May 8, 2017 | Delisting 25-NSE | Read ↗ |
| Mar 17, 2017 | Annual report 20-F | Read ↗ |
Source: GSK plc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on GSK
Company overviewEverything on GSK in one place, with the price.Who owns itEvery manager reporting a position in GSK.Funds holding itWhich funds and ETFs hold GSK, and how big a bet.LobbyingWhat GSK spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on GSK's account, and who they worked for.PatentsWhat GSK is filing at the patent office.